{"schema_version":"secwatch.filing_event.v1","accession":"0001179929-26-000026","form_type":"8-K","ticker":"MOH","cik":"0001179929","company_name":"MOLINA HEALTHCARE, INC.","filed_at":"2026-05-11T13:02:19+00:00","discovered_at":"2026-05-11T14:49:57.127956+00:00","generated_at":"2026-05-11T18:19:54.223243+00:00","sec_items":["5.02","5.07","5.03","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Molina shareholders approve 1.5M share increase to equity plan and 20% special meeting right","bullets":["Approved amendment to 2025 Equity Incentive Plan increasing authorized shares from 1,795,000 to 3,295,000 (1.5M new shares).","Approved certificate amendment enabling stockholders with at least 20% voting power to call special meetings.","Board adopted amended bylaws with procedural conditions for special meeting requests, including one-year holding period.","Advisory say-on-pay vote passed with 22.5M for vs 20.1M against; all ten director nominees elected.","Ratified Ernst & Young as independent auditor for 2026 with 45.9M votes for."],"urls":{"canonical":"https://secwatch.observer/filing/0001179929-26-000026","json":"https://secwatch.observer/filing/0001179929-26-000026.json","markdown":"https://secwatch.observer/filing/0001179929-26-000026.md","text":"https://secwatch.observer/filing/0001179929-26-000026.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1179929/000117992926000026/0001179929-26-000026-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1179929/000117992926000026/moh-20260506.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-11T18:19:54.223243+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"38985d93f410a581d5f59a387f3bc737e97306ee","claim":"MOLINA HEALTHCARE, INC.: Amended certificate of incorporation to allow stockholders holding at least 20% voting power to call special meetings (effective 2026-05-06).","evidence_excerpt":"On May 6, 2026, at the Annual Meeting, as further described in Item 5.07 below, the Company’s stockholders approved an amendment to the Company’s Amended and Restated Certificate of Incorporation to allow stockholders holding at least 20% of the voting power of the outstanding shares of capital stock of the Company to call a special meeting of stockholders","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1179929/000117992926000026/0001179929-26-000026-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2026-05-06"}],"fact_type":"governance_change"},{"claim_id":"491c930d1e66f7e0c6b36ef2d2a2dee0eebf4d59","claim":"MOLINA HEALTHCARE, INC.: Amended and restated bylaws to implement procedures for special meetings called by stockholders and make technical changes (effective 2026-05-06).","evidence_excerpt":"on May 6, 2026, the Company’s Board of Directors (the “Board”) approved and adopted an amendment and restatement of the Company’s Amended and Restated Bylaws (as so amended and restated, the “Amended and Restated Bylaws”), effective immediately","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1179929/000117992926000026/0001179929-26-000026-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"bylaw amendment"},{"label":"Effective","value":"2026-05-06"}],"fact_type":"governance_change"},{"claim_id":"24b04f1e226dc8b21810ba0e34cc69c1d7fb445a","claim":"MOLINA HEALTHCARE, INC. shareholders approved Election of the ten directors named below to hold office until the 2027 annual meeting at the 2026-05-06 meeting.","evidence_excerpt":"With regard to Proposal No. 1, for the election of the ten directors named below to hold office until the 2027 annual meeting, the stockholders voted as follows: Director Votes For Votes Against Abstentions Broker Non-Votes Barbara L. Brasier 41,403,098 1,173,580 50,838 4,545,112 Leo P. Grohowski 41,418,155 1,159,784 49,577 4,545,112 Stephen H. Lockhart 42,374,279 205,101 48,136 4,545,112 Steven J. Orlando 40,955,995 1,620,889 50,632 4,545,112 Ronna E. Romney 38,461,391 4,035,124 131,001 4,545,112 Richard M. Schapiro 42,174,723 403,527 49,266 4,545,112 Francis S. Soistman 42,371,936 199,759 55,821 4,545,112 Dale B. Wolf 39,097,714 3,479,902 49,900 4,545,112 Richard C. Zoretic 42,369,441 210,513 47,562 4,545,112 Joseph M. Zubretsky 42,327,641 277,647 22,228 4,545,112","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1179929/000117992926000026/0001179929-26-000026-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-05-06"}],"fact_type":"shareholder_vote"},{"claim_id":"4b81bafb29e32200f03e583f4961750eb0d41c3e","claim":"MOLINA HEALTHCARE, INC. shareholders approved Approval of an amendment to the Company's 2025 Equity Incentive Plan to increase the number of shares available for issuance under such plan at the 2026-05-06 meeting.","evidence_excerpt":"With regard to Proposal No. 4, for the approval of an amendment to the Company’s 2025 Equity Incentive Plan to increase the number of shares available for issuance under such plan, the stockholders voted as follows: Votes For Votes Against Abstentions Broker Non-Votes 31,318,146 11,285,569 23,801 4,545,112","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1179929/000117992926000026/0001179929-26-000026-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"equity plan"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-05-06"}],"fact_type":"shareholder_vote"},{"claim_id":"71c674e3f62797407cbda311c208aef5c1f790f4","claim":"MOLINA HEALTHCARE, INC. shareholders approved Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for 2026 at the 2026-05-06 meeting.","evidence_excerpt":"With regard to Proposal No. 3, for the ratification of the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for 2026, the stockholders voted as follows: Votes For Votes Against Abstentions Broker Non-Votes 45,850,249 1,293,650 28,729 0","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1179929/000117992926000026/0001179929-26-000026-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-05-06"}],"fact_type":"shareholder_vote"},{"claim_id":"924d58ae84961b6996d16830e0159363fa12764d","claim":"MOLINA HEALTHCARE, INC. shareholders approved Approval of an amendment to the Company's Certificate of Incorporation to permit stockholders to call special stockholders meetings at the 2026-05-06 meeting.","evidence_excerpt":"With regard to Proposal No. 5, for the approval of an amendment to the Company’s Certificate of Incorporation to permit stockholders to call special stockholders meetings, the stockholders voted as follows: Votes For Votes Against Abstentions Broker Non-Votes 42,570,475 42,704 14,337 4,545,112","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1179929/000117992926000026/0001179929-26-000026-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"charter amendment"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-05-06"}],"fact_type":"shareholder_vote"},{"claim_id":"b94323fd8b61df7012edd4831906a8ac57293c21","claim":"MOLINA HEALTHCARE, INC. shareholders approved Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers at the 2026-05-06 meeting.","evidence_excerpt":"With regard to Proposal No. 2, for the approval, on a non-binding, advisory basis, of the compensation of the Company’s named executive officers, the stockholders voted as follows: Votes For Votes Against Abstentions Broker Non-Votes 22,459,321 20,116,888 51,307 4,545,112","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1179929/000117992926000026/0001179929-26-000026-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-05-06"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}